Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment

BACKGROUND: It is lacking that markers could predict the prognosis of chronic hepatitis B (CHB) subjects during antiviral treatment, and the related cellular immune mechanism is not fully evaluated. AIM: To explore the comprehensive profile of T cell receptor β-chain (TRBV) and CD4+CD25+ regulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiezuan, Lu, Haifeng, Chen, Baikun, Jiang, Lili, Zhang, Hua, Ye, Ping, Jin, Linfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845053/
https://www.ncbi.nlm.nih.gov/pubmed/36660247
http://dx.doi.org/10.1155/2023/1914036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845053/
https://www.ncbi.nlm.nih.gov/pubmed/36660247
http://dx.doi.org/10.1155/2023/1914036

Ejemplares similares